Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Synsorb Pk receives fast track designation from FDA for prevention of HUS

March 20, 2000

Clinical trials of (S)-doxazosin in BPH commenced

March 15, 2000

Detrusitol available in Spain for hyperactive bladder

March 14, 2000

Novel dihydropyrimidines from Merck are potent and selective alpha1A-adrenoceptor antagonists

March 14, 2000

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

March 10, 2000

New 5alpha-reductase inhibitors in the pipeline at Kotobuki

March 8, 2000

Merck returns alpha-adrenergic technology rights to Synaptic

March 7, 2000

C5 inhibitor from Alexion granted fast track status for kidney disease

March 2, 2000

Dosing begins in phase II trial of Alprox-TD for erectile dysfunction

Feb. 28, 2000

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Feb. 25, 2000

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...